• Profile
Close

Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): A multicentre, randomised, controlled phase 2 trial

The Lancet Respiratory Medicine Sep 07, 2018

Raghu G, et al. - In the WRAP-IPF trial, researchers investigated the impact of treatment of abnormal acid gastro-oesophageal reflux (GER) with laparoscopic anti-reflux surgery on the rate of idiopathic pulmonary fibrosis (IPF) progression. Laparoscopic anti-reflux surgery proved safe and was well tolerated among patients with IPF and abnormal acid GER.

Methods

  • Researchers performed the WRAP-IPF trial, which was a randomised controlled trial of laparoscopic anti-reflux surgery in patients with IPF and abnormal acid GER; the patients were recruited from six academic centres in the USA.
  • Patients with IPF, abnormal acid GER (DeMeester score of ≥14·7; measured by 24-h pH monitoring) and preserved forced vital capacity (FVC) were enrolled.
  • Patients were excluded if they had FVC below 50% predicted, a FEV1/FVC ratio of less than 0·65, a history of acute respiratory illness in the past 12 weeks, a body-mass index greater than 35, and known severe pulmonary hypertension.
  • They allowed concomitant therapy with nintedanib and pirfenidone.
  • Change in FVC from randomisation to week 48 was assessed as the primary endpoint, in the intention-to-treat population with mixed-effects models for repeated measures. 

Results

  • Seventy two patients were screened from June 1, 2014, to Sept 30, 2016, of these, 58 were assigned to receive surgery (n=29) or no surgery (n=29).
  • An FVC measurement at 48 weeks was performed in 27 patients in the surgery group and 20 patients in the no surgery group (p=0·041).
  • The adjusted rate of change in FVC over 48 weeks was −0·05 L (95% CI −0·15 to 0·05) in the surgery group and −0·13 L (−0·23 to −0·02) in the non-surgery group in the intention-to-treat analysis adjusted for baseline anti-fibrotic(p=0·28).
  • The surgery group had less frequent acute exacerbation, respiratory-related hospitalisation, and death.
  • The most common adverse events after surgery included dysphagia (eight [29%] of 28) and abdominal distention (four [14%] of 28).
  • One death in the surgery group and four deaths in the non-surgery group were reported.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay